Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines.

[1]  R. Jaffe,et al.  Role of vascular endothelial growth factor in ovarian physiology and pathology. , 2000, Fertility and sterility.

[2]  A. Murdoch,et al.  Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox. , 2000, Fertility and sterility.

[3]  R. Casamitjana,et al.  Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response. , 2000, Human reproduction.

[4]  Y. S. Yang,et al.  Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome. , 2000, Human reproduction.

[5]  W. Jiménez,et al.  Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients , 1999, Hepatology.

[6]  W. Jiménez,et al.  Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: Regulation by cytokines and bacterial lipopolysaccharide , 1999, Hepatology.

[7]  A. Mercader,et al.  The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. , 1999, Fertility and sterility.

[8]  V. Arroyo,et al.  Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome. , 1998, Human reproduction.

[9]  W. Jiménez,et al.  Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. , 1998, Human reproduction.

[10]  R. Casamitjana,et al.  Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators. , 1998, The Journal of clinical endocrinology and metabolism.

[11]  J. Jenkins,et al.  The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome. , 1997, Human reproduction.

[12]  J. Schenker,et al.  The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. , 1997, Human reproduction.

[13]  J. Smitz,et al.  The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. , 1997, Human reproduction update.

[14]  M. Friedlander,et al.  Elevated Interleukin‐6 Levels in the Ovarian Hyperstimulation Syndrome: Ovarian Immunohistochemical Localization of Interleukin‐6 Signal , 1996, Obstetrics and gynecology.

[15]  W. Jiménez,et al.  Neurohormonal and Hemodynamic Changes in Severe Cases of the Ovarian Hyperstimulation Syndrome , 1994, Annals of Internal Medicine.

[16]  J. Laragh,et al.  Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. , 1994, The Journal of clinical endocrinology and metabolism.

[17]  J. Llach,et al.  Severe ovarian hyperstimulation syndrome: Role of peripheral vasodilation , 1991, Fertility and sterility.

[18]  A. Golan,et al.  Ovarian hyperstimulation syndrome: an update review. , 1989 .